Healthcare-associated infections (HAIs) stand as a profound international threat, affecting the safety of patients and influencing overall healthcare costs. Addressing this issue, this op-ed discusses a game-changing tool in the battle against airborne pathogens: Far-UVC light. Co-authored by experts in healthcare, optical radiation, policy-making, law, and toxicology, this piece embodies a shared commitment to maintaining public health and reducing health hazards, regardless of geographic or educational disparities.
The impact of HAIs cannot be overstated. As per the HAI Progress Report from the Centers for Disease Control and Prevention (CDC), one out of 31 hospital patients and one in 43 nursing home residents in the United States become victims of HAIs. This issue is not confined to the US; across the Atlantic, the European Centre for Disease Prevention and Control reports that HAIs result in nearly 23,000 deaths annually in England. Moreover, the statistics from Scotland indicate that one in every 100 hospital patients feels the effects of HAIs. The implications are severe – lives are put at risk, healthcare expenses escalate, recovery times lengthen, and there is significant pressure on healthcare resources.
Although numerous methods to tackle HAIs exist, such as upgrading ventilation and enhancing indoor air sanitization, these are not wholly effective in eliminating all airborne pathogens. A holistic approach is needed, one which incorporates multiple tools to protect public health. Here, the promising potential of Far-UVC light comes into play.
Far-UVC light refers to a particular type of ultraviolet light within the 222-nanometer wavelength. Indeed this signals an innovative step forward in the realm of pathogen control. In contrast with conventional UVC light which has been widely utilized to neutralize airborne viruses and bacteria, Far-UVC light eliminates pathogens without posing risks to human skin or eyes, allowing it to be used safely in spaces where people gather, such as hospitals or public areas.
This revolutionary technology suggests a future where airborne pathogens below the size threshold of ventilation systems can be targeted and eradicated in hospital rooms, via the simple activation of a Far-UVC system. Research-backed, this could drastically reduce the transmission of HAIs and save lives. The potential value of such technology escalates in situations like the COVID-19 pandemic, where airborne transmission constitutes a prominent danger.
Despite its promise in healthcare settings, the implementation of Far-UVC technology merits careful consideration. Research is ongoing to fully understand its impact on indoor ozone and particulate matter levels, to ensure its safety for long-term use in occupied spaces. However, the urgency drummed up by the necessity to reduce HAIs and blood-borne pathogens warrants immediate, serious consideration of Far-UVC light, specifically as a part of a layered strategy for indoor air decontamination.
Reflecting personal experiences and leveraging statistical data, the discussion around Far-UVC technology puts the spotlight prominently on the importance of preventing disease and improving lives in public health. The time is ripe to bring this ground-breaking Far-UVC technology to the fore and integrated into places where it’s most urgently needed. This can contribute to saving lives, alleviating suffering, and instilling hope in vulnerable patients – outcomes that are indeed priceless.
It’s crucial to note, the opinions formulated in this article represent the authors’ perspectives and do not necessarily echo the views or policies of Johns Hopkins University or Ninewells Hospital.
Source: https://www.infectioncontroltoday.com/view/far-uvc-is-public-health-tool-we-need-now